Skip to Main Content

Paper Details

Stochastic Interventional Vaccine Efficacy and Principal Surrogate Analyses of Antibody Markers as Correlates of Protection against Symptomatic COVID-19 in the COVE mRNA-1273 Trial.
0
2023
Anti-SARS-CoV-2 Spike IgG binding antibodies, COVE, COVID-19, CoPs, D29, D57, D57 markers, IgG, SARS-CoV-2, Spike IgG, anti-, mRNA, participants
Author NameAffiliation
David C MontefioriDuke Human Vaccine Institute, Duke University Medical Center
Adrian B McDermottVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • 1 - 2

Datasets

Release 1.2